chlamydocin (Johnson & Johnson)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namechlamydocin (Johnson & Johnson)

Drug Alias NameChlamydocinHDAC inhibitor peptide (J&J)histone deacetylase inhibitor peptide (J&J)histone deacetylase inhibitor peptide (Johnson & Johnson)HDAC inhibitor peptide (Johnson & Johnson)

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionHistone deacetylase inhibitors

TargetsHistone deacetylase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohnson & Johnson

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJohnson & Johnson

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A